Bone scan or (18)f-fluorodeoxyglucose positron emission tomography/computed tomography; which modality better shows bone metastases of breast cancer?

作者: Tansel A. Balci , Zehra P. Koc , Halil Komek

DOI: 10.1159/000341559

关键词:

摘要: Background: In this multicenter study, we aimed to compare concurrent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) and bone scan results of breast cancer patient. Patients Methods: 162 patients with (158 female, 4 male; mean age 50.6 years) were included in the study. FDG PET/CT examination was performed all patients, scintigraphy 68 patients. The compared. Results: 132 operated on because cancer. 89 had metastasis, recurrent disease according PET/ CT results. Metastatic sites order frequency lymph nodes, bone, lung, liver, adrenal gland, local skin or muscle, brain, peritoneum (peritonitis carcinomatosa). sensitivity, specificity, accuracy, negative positive predictive value versus 96 vs. 100%, 100 98%, 83%, 90 vs.100%, respectively. Conclusion: Although 2 modalities concordance each other, 5 (21%) cases, could not show metastasis which detected scintigraphy. Hence, superior determination derived from However, should be considered for soft tissue metastasis.

参考文章(20)
Nasuda Danchaivijitr, Sunanta Chiewvit, Pipat Chiewvit, Kaewta Sirivitmaitrie, Kullatorn Thephamongkhol, Does magnetic resonance imaging give value-added than bone scintigraphy in the detection of vertebral metastasis? Journal of the Medical Association of Thailand Chotmaihet thangphaet. ,vol. 92, pp. 818- ,(2009)
Isabelle Segaert, Felix Mottaghy, Sarah Ceyssens, Walter De Wever, Sigrid Stroobants, Chantal Van Ongeval, Eric Van Limbergen, Hans Wildiers, Robert Paridaens, Ignace Vergote, Marie-Rose Christiaens, Patrick Neven, Additional Value of PET–CT in Staging of Clinical Stage IIB and III Breast Cancer Breast Journal. ,vol. 16, pp. 617- 624 ,(2010) , 10.1111/J.1524-4741.2010.00987.X
G J Cook, S Houston, R Rubens, M N Maisey, I Fogelman, Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. Journal of Clinical Oncology. ,vol. 16, pp. 3375- 3379 ,(1998) , 10.1200/JCO.1998.16.10.3375
Ora Israel, Anat Goldberg, Alicia Nachtigal, Daniela Militianu, Rachel Bar-Shalom, Zohar Keidar, Ignac Fogelman, FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 33, pp. 1280- 1284 ,(2006) , 10.1007/S00259-006-0141-3
Yu-Wen Chen, Ming-Yii Huang, Jan-Sing Hsieh, Ming-Fung Hou, Shah-Hwa Chou, Chih-Liang Lin, Discordant Findings of Skeletal Metastasis Between Tc99m MDP Bone Scans and F18 FDG PET/CT Imaging for Advanced Breast and Lung Cancers—Two Case Reports and Literature Review Kaohsiung Journal of Medical Sciences. ,vol. 23, pp. 639- 646 ,(2007) , 10.1016/S1607-551X(08)70064-0
A. Kurata, Y. Murata, K. Kubota, T. Osanai, H. Shibuya, Multiple 18f-fdg, pet-ct for postoperative monitoring of breast cancer patients: Acta Radiologica. ,vol. 50, pp. 979- 983 ,(2009) , 10.3109/02841850903147046
Steffen Hahn, Till Heusner, Sherko Kümmel, Angelika Köninger, James Nagarajah, Stefan Müller, Christian Boy, Michael Forsting, Andreas Bockisch, Gerald Antoch, Alexander Stahl, Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer: Acta Radiologica. ,vol. 52, pp. 1009- 1014 ,(2011) , 10.1258/AR.2011.100507
Takako Nakai, Chio Okuyama, Takao Kubota, Kei Yamada, Yo Ushijima, Keiko Taniike, Takako Suzuki, Tsunehiko Nishimura, Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 32, pp. 1253- 1258 ,(2005) , 10.1007/S00259-005-1842-8